Is Parenteral Levothyroxine Therapy Safe in Intractable Hypothyroidism?

J Natl Med Assoc

Uludag University, Department of Endocrinology and Metabolic Disorders, Turkey.

Published: June 2018

Case: A 32-year old woman was admitted to the hospital due to intractable hypothyroidism refractory to high dose of oral l-thyroxine therapy. She underwent total thyroidectomy and radioactive iodine therapy due to papillary thyroid cancer. After excluding poor adherence to therapy and malabsorption, levothyroxine absorption test was performed. No response was detected. Transient neurologic symptoms developed during the test. She developed 3 attacks consisting of neurologic symptoms during high dose administration. The patient was considered a case of isolated l-thyroxine malabsorption. She became euthyroid after intramuscular twice weekly l-thyroxine therapy.

Discussion: There are a few case reports regarding isolated l-thyroxine. We report successful long term results of twice weekly administered intramuscular l-thyroxine therapy. We also draw attention to neurologic side effects of high dose l-thyroxine therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jnma.2017.05.007DOI Listing

Publication Analysis

Top Keywords

high dose
12
l-thyroxine therapy
12
neurologic symptoms
8
isolated l-thyroxine
8
therapy
6
l-thyroxine
6
parenteral levothyroxine
4
levothyroxine therapy
4
therapy safe
4
safe intractable
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!